Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 10.1B 1.5B 1.29B 1.22B 1.11B 2.08B 143B 2.11B 14.24B 5.57B 71.72B 5.62B 5.5B 238B P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 9.26B 1.37B 1.19B 1.11B 1.01B 1.91B 131B 1.94B 13.06B 5.11B 65.77B 5.16B 5.04B 219B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 day+6.59%
1 week+45.19%
Current month+58.95%
1 month+49.01%
3 months+41.12%
6 months+36.04%
Current year+47.56%
1 week 3.26
Extreme 3.26
4.68
1 month 2.72
Extreme 2.72
4.68
Current year 2.37
Extreme 2.37
4.68
1 year 2.37
Extreme 2.37
4.68
3 years 1.66
Extreme 1.66
4.68
5 years 1.66
Extreme 1.66
4.68
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 25/12/2022
Corporate Officer/Principal 42 17/04/2018
Corporate Officer/Principal 40 22/05/2019
Director TitleAgeSince
Director/Board Member 40 13/03/2025
Director/Board Member 53 10/11/2022
Director/Board Member 42 10/11/2022
Date Insider Type Main position Quantity % Market Cap.
02/07/25 Sell 587,500 0.0283%
02/07/25 Sell

Director

259,600 0.0125%
02/07/25 Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
+6.59%+45.19%+20.80%+99.56% 1.5B
-0.10%-0.77%+17.58%+70.16% 48.43B
-3.26%-5.31%+53.19%+117.23% 39.72B
-0.60%-0.94%-7.29%+17.35% 12.25B
-2.75%+1.88%+14.81%+76.92% 11.84B
-0.19%-0.38%+30.40%+135.91% 9.06B
+1.56%+5.52%+23.46%+39.78% 7.57B
+0.52%+2.08%+40.75%-12.45% 7.18B
-0.07%+1.72%+13.39%+190.65% 6.84B
-2.51%-3.14%-27.46%+24.20% 5.77B
Average -0.08%+4.56%+17.96%+75.93% 15.02B
Weighted average by Cap. -1.10%+1.34%+25.04%+81.34%

Financials

2024 2025
Net sales 2.44B 362M 313M 294M 267M 502M 34.6B 510M 3.44B 1.35B 17.33B 1.36B 1.33B 57.58B 2.14B 317M 273M 257M 234M 439M 30.28B 447M 3.01B 1.18B 15.16B 1.19B 1.16B 50.38B
Net income 233M 34.51M 29.81M 28.01M 25.47M 47.89M 3.3B 48.68M 328M 128M 1.65B 130M 127M 5.49B 377M 55.88M 48.27M 45.35M 41.25M 77.55M 5.34B 78.83M 531M 208M 2.68B 210M 205M 8.89B
Net Debt -509M -75.42M -65.14M -61.21M -55.67M -105M -7.21B -106M -717M -280M -3.61B -283M -277M -12B -838M -124M -107M -101M -91.72M -172M -11.88B -175M -1.18B -462M -5.95B -467M -456M -19.77B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
14/08/26 CN¥4.530 +6.59% 929,751,663
13/08/26 CN¥4.250 +10.10% 480,880,080
12/08/26 CN¥3.860 +9.97% 538,249,196
11/08/26 CN¥3.510 +2.33% 589,932,482
10/08/26 CN¥3.430 +9.94% 461,491,797

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock